Skyhawk Therapeutics Announces Positive First Interim Results in Patients from its Phase 1 Clinical Trial of SKY-0515 as a Treatment for Huntington’s Disease
SKY-0515 achieves dose-dependent reductions of mutant huntingtin (mHTT) protein, with 62% lowering…
AM Best Withdraws Credit Ratings of Agrinational Insurance Company
OLDWICK, N.J.--(BUSINESS WIRE)--#insurance--AM Best has affirmed the Financial Strength Rating of A-…
ACKO Drive Brings Unbeatable Discounts on Maruti Suzuki Cars for July 2025
BENGALURU, India, Aug. 1, 2025 /PRNewswire/ -- For someone who has been…
Scancell reports Phase 2 data showing strongly improved outcomes in Late-Stage Melanoma with its Immunobody iSCIB1+
July 22, 2025 02:00 ET | Source: Scancell Holdings Plc SCOPE trial…
Five-year Pharmacovigilance study by NTC confirms safety of fixed-dose eye drops for Post-cataract Surgery
MILAN, July 17, 2025 /PRNewswire/ -- A recently published five-year pharmacovigilance study confirms…
QS Best Student Cities Ranking 2026
London slips, Seoul crowned #1, Asia rises LONDON, July 15, 2025 /PRNewswire/…
Microban International Unveils H2O Shield, a Portfolio of PFAS-Free Water-Resistant Textile Technologies
Tailored solutions provide excellent water repellency while addressing key concerns such as…